Explore the full record of transactions filed by ZACCARDELLI DAVID, Chief Executive Officer. Insider active across 1 companies, notably Verona Pharma plc. In total, 12 filings have been published. Total volume traded: €38k. The latest transaction was filed on 3 May 2022 — Cession. Regulator: SEC (Form 4). The full history is openly available.
David Zaccardelli is the President and CEO of Verona Pharma plc. He leads the company's operations, focused on developing innovative treatments for respiratory diseases. With a strong background in the pharmaceutical industry, he is committed to advancing research and improving patient outcomes. His leadership is crucial for the growth strategy and success of Verona Pharma.